Skip to content
OpenCapital
Get started

Capricor Therapeutics CAPR EBITDA

EBITDA at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$60.37M-93.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$83.58M-35.1%
Vericel logo
VericelVCEL
-$4.8M+52.5%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$116.05M-23.8%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$124.73M-2.3%
Pfizer logo
PfizerPFE
——

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Calculated from Capricor Therapeutics’s reported figures.

−$36.8Mebit+
$534.7KDepreciation Depletion & Amortization
=-$36.24M

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's EBITDA?
Capricor Therapeutics (CAPR) reported EBITDA of -$36.24M in Q1 2026.
How has Capricor Therapeutics's EBITDA changed year-over-year?
Capricor Therapeutics's EBITDA decreased by 47.4% year-over-year, from -$24.58M to -$36.24M.
What is the long-term trend for Capricor Therapeutics's EBITDA?
Over 4 years (2021 to 2025), Capricor Therapeutics's EBITDA has grown at a 50.5% compound annual growth rate (CAGR), from -$20.69M to -$106.25M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.